Blood Thinning Drug Xarelto May Cause Brain Bleeding
Blood thinning drugs have gained an unenviable reputation in recent years. The latest drug to lead to a spate of lawsuits is Xarelto
The drug which is also known as rivaroxaban is one of the newest anticoagulants – more commonly known as blood thinners. It’s an oral medication developed by Bayer and Johnson & Johnson’s New Jersey-based unit, Janssen Pharmaceuticals.
Blood thinners were developed to prevent dangerous blood clots that can obstruct the blood flow to the vital organs of the body. Xarelto is different from older anticoagulants that require doctors to prescribe specific doses for each person. It belongs to a new type of oral anticoagulant that is prescribed in one uniform dose.
The Food and Drug Administration (FDA) has approved Xarelto for use in patients who have who have had hip or knee replacement surgery. It’s meant to reduce the danger of blood clots, reducing the risk of stroke in people with AF. The drug underwent a fast track review which is usually a red flag for personal injury lawyers. The FDA approved the drug for general treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).
Unfortunately, Xarelto carries severe potential side effects such of the danger of uncontrolled bleeding in important organs such as the brain, lungs or kidneys. Drugwatch states “pools of blood may form within the body and can cause other severe health risks.”
Because Xarelto prevents clotting hemorrhaging will continue until the drug is flushed out of the body’s system.
These are very serious and potentially life-threatening side effects. Last year I wrote about a rise in lawsuits brought over the blood thinning drug Pradaxa.
If you or a loved one has been harmed by a prescribed drug, you may have a case for a products liability lawsuit. See our Virginia injury lawyers’ information about dangerous drugs or call Cooper Hurley Injury Lawyers at 757.455.0077.